top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2018
Descrizione fisica 1 online resource (iv, 51 pages)
Soggetto topico Drugs - United States - Testing
Drug approval - United States
Drugs - Safety regulations - United States
Medical instruments and apparatus - Safety regulations - United States
Generic drugs - United States
Competition - United States
Antitrust law - United States
Antitrust law
Competition
Drug approval
Drugs - Safety regulations
Drugs - Testing
Generic drugs
Medical instruments and apparatus - Safety regulations
Soggetto genere / forma Legislative hearings.
Rules.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Antitrust concerns and the FDA approval process
Record Nr. UNINA-9910709758903321
Washington : , : U.S. Government Publishing Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Descrizione fisica 1 online resource (iii, 98 p.) : ill
Soggetto topico Drugs - Safety regulations - United States
Soggetto non controllato United States
Drugs
Political science
Medical
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Building a 21st century FDA
Record Nr. UNINA-9910694377503321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Dietary supplements and FDA use of adverse event reports / / William M. Forsberg, editor
Dietary supplements and FDA use of adverse event reports / / William M. Forsberg, editor
Pubbl/distr/stampa New York : , : Novinka, , [2013]
Descrizione fisica 1 online resource (94 pages) : illustrations
Disciplina 615.1028/9
Collana Public health in the 21st century
Nutrition and diet research progress
Soggetto topico Dietary supplements - Safety regulations - United States
Drugs - Safety regulations - United States
ISBN 1-62808-024-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910151729803321
New York : , : Novinka, , [2013]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010
Pubbl/distr/stampa Washington : , : U.S. Government Printing Office, , 2012
Descrizione fisica 1 online resource (v, 81 pages)
Soggetto topico Drugs - Safety regulations - United States
Pharmaceutical policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug safety
Record Nr. UNINA-9910704334103321
Washington : , : U.S. Government Printing Office, , 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Descrizione fisica 1 online resource (iii, 99 p.) : ill
Soggetto topico Drugs - Safety regulations - United States
Drugs - United States - Testing
Soggetto non controllato United States
Drugs
Political science
Medical
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Ensuring drug safety
Record Nr. UNINA-9910693918303321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2016
Descrizione fisica 1 online resource (v, 146 pages)
Soggetto topico Generic drugs - Labeling - United States
Drugs - Safety regulations - United States
Warning labels - Government policy - United States
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Examining concerns regarding FDA's proposed changes to generic drug labeling
Record Nr. UNINA-9910707021503321
Washington : , : U.S. Government Publishing Office, , 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Restoring FDA's ability to keep America's families safe [[electronic resource] ] : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008
Restoring FDA's ability to keep America's families safe [[electronic resource] ] : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008
Pubbl/distr/stampa Washington : , : U.S. G.P.O., , 2009
Descrizione fisica iii, 47 pages ; ; 24 cm
Collana S. hrg.
Soggetto topico Food - Safety regulations - United States
Drugs - Safety regulations - United States
Food - Safety measures - Government policy - United States
Drugs - Safety measures - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Restoring FDA's ability to keep America's families safe
Record Nr. UNINA-9910702826803321
Washington : , : U.S. G.P.O., , 2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Risk and responsibility : the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
Risk and responsibility : the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
Descrizione fisica 1 online resource (iii, 140 p.) : ill
Soggetto topico Rofecoxib - Testing
Nonsteroidal anti-inflammatory agents - United States - Testing
Nonsteroidal anti-inflammatory agents - Safety regulations - United States
Drugs - United States - Testing
Drugs - Safety regulations - United States
Soggetto non controllato Drugs
Medical
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Risk and responsibility
Record Nr. UNINA-9910693935903321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Science and mission at risk : FDA's self-assessment : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, January 29, 2008
Science and mission at risk : FDA's self-assessment : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, January 29, 2008
Pubbl/distr/stampa Washington : , : U.S. Government Printing Office, , 2008
Descrizione fisica 1 online resource (iii, 456 pages) : illustrations
Soggetto topico Food - Safety regulations - United States
Drugs - Safety regulations - United States
Food - Safety measures - Government policy - United States
Drugs - Safety measures - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Science and mission at risk
Record Nr. UNINA-9910706702203321
Washington : , : U.S. Government Printing Office, , 2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui